OVERCOMING HYPOMETHYLATING AGENTS' TOXICITY AND NONSPECIFICITY USING AN APTAMER-BASED STRATEGY TO CORRECT ABERRANT DNA METHYLATION IN MYELODYSPLASTIC SY

Beth Israel Deaconess Medical Center, Inc.

Investigators